DNAJC5 and malaria: An Ad-based malaria vaccine that expressed a B cell epitope derived from the P. yoelii CSP within the HVR 1 of Ad5 enhanced the level of protection against an experimental challenge when compared with unmodified Ad5 expressing CSP [28].